Curran Simpson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Curran Simpson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Curran Simpson. Curran Simpson is Sr. VP, Operations in HUMAN GENOME SCIENCES INC ($HGSI) and Chief Oper. & Tech. Officer in REGENXBIO Inc. ($RGNX) and See Remarks in REGENXBIO Inc. ($RGNX) and SVP of Technical Operations in REGENXBIO Inc. ($RGNX) and SVP, Product Development & CTO in REGENXBIO Inc. ($RGNX) and SVP, Technical Operations in REGENXBIO Inc. ($RGNX).
Latest Insider Trading Transactions of Curran Simpson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 35.80 | 10,372 | 371,318 | 17,128 | |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 1,240 | 24,180 | 0 | |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 1,700 | 33,150 | 1,240 | |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.01 | 11,612 | 580,716 | 17,748 | 29.4 K to 17.7 K (-39.55 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 35.80 | 10,372 | 371,318 | 29,360 | 19 K to 29.4 K (+54.62 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 1,240 | 24,180 | 18,988 | 17.7 K to 19 K (+6.99 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.03 | 1,700 | 85,051 | 17,748 | 19.4 K to 17.7 K (-8.74 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 1,700 | 33,150 | 19,448 | 17.7 K to 19.4 K (+9.58 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 5,185 | 101,108 | 2,940 | |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.01 | 5,185 | 259,302 | 17,748 | 22.9 K to 17.7 K (-22.61 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 5,185 | 101,108 | 22,933 | 17.7 K to 22.9 K (+29.21 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | A | 44.97 | 62,300 | 2,801,631 | 62,300 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Grant | A | 0.00 | 13,800 | 0 | 17,748 | 3.9 K to 17.7 K (+349.54 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 6,633 | 145,926 | 0 | |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 4,253 | 82,934 | 8,125 | |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 14,928 | 328,416 | 6,633 | |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 12,479 | 446,748 | 27,500 | |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 51.37 | 3,692 | 189,658 | 3,948 | 7.6 K to 3.9 K (-48.32 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.13 | 8,872 | 444,753 | 7,640 | 16.5 K to 7.6 K (-53.73 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 6,633 | 145,926 | 16,512 | 9.9 K to 16.5 K (+67.14 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.22 | 44,429 | 2,231,224 | 9,879 | 54.3 K to 9.9 K (-81.81 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 12,479 | 446,748 | 54,308 | 41.8 K to 54.3 K (+29.83 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 14,928 | 328,416 | 41,829 | 26.9 K to 41.8 K (+55.49 %) |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 4,253 | 82,934 | 26,901 | 22.6 K to 26.9 K (+18.78 %) |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 13.09 | 2,708 | 35,448 | 0 | |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,000 | 19,500 | 12,378 | |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 958 | 21,076 | 21,561 | |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 471 | 16,862 | 39,979 | |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.00 | 5,637 | 281,850 | 22,648 | 28.3 K to 22.6 K (-19.93 %) |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 471 | 16,862 | 28,285 | 27.8 K to 28.3 K (+1.69 %) |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 958 | 21,076 | 27,814 | 26.9 K to 27.8 K (+3.57 %) |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,000 | 19,500 | 26,856 | 25.9 K to 26.9 K (+3.87 %) |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 13.09 | 2,708 | 35,448 | 25,856 | 23.1 K to 25.9 K (+11.70 %) |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,622 | 31,629 | 13,378 | |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 2,700 | 59,400 | 22,519 | |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 800 | 28,640 | 40,450 | |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.00 | 5,922 | 296,100 | 23,148 | 29.1 K to 23.1 K (-20.37 %) |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 800 | 28,640 | 29,070 | 28.3 K to 29.1 K (+2.83 %) |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 2,700 | 59,400 | 28,270 | 25.6 K to 28.3 K (+10.56 %) |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,622 | 31,629 | 25,570 | 23.9 K to 25.6 K (+6.77 %) |
| Dec 11 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 44.26 | 6,153 | 272,332 | 23,948 | 30.1 K to 23.9 K (-20.44 %) |
| Dec 11 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 43.40 | 9,399 | 407,917 | 30,101 | 39.5 K to 30.1 K (-23.79 %) |
| May 30 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 18,000 | 396,000 | 25,219 | |
| May 30 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.00 | 18,000 | 900,000 | 39,500 | 57.5 K to 39.5 K (-31.30 %) |
| May 30 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 18,000 | 396,000 | 57,500 | 39.5 K to 57.5 K (+45.57 %) |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 5,300 | 189,740 | 41,250 | |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 54.05 | 5,300 | 286,465 | 39,500 | 44.8 K to 39.5 K (-11.83 %) |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 5,300 | 189,740 | 44,800 | 39.5 K to 44.8 K (+13.42 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 13.09 | 625 | 8,181 | 2,708 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,875 | 36,563 | 15,000 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 32,882 | 723,404 | 43,219 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 8,450 | 302,510 | 46,550 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.08 | 43,832 | 2,195,107 | 39,500 | 83.3 K to 39.5 K (-52.60 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 13.09 | 625 | 8,181 | 83,332 | 82.7 K to 83.3 K (+0.76 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,875 | 36,563 | 82,707 | 80.8 K to 82.7 K (+2.32 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 32,882 | 723,404 | 80,832 | 48 K to 80.8 K (+68.58 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 8,450 | 302,510 | 47,950 | 39.5 K to 48 K (+21.39 %) |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | A | 40.82 | 46,000 | 1,877,720 | 46,000 | |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 32,882 | 723,404 | 76,101 | |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 64.71 | 15,494 | 1,002,617 | 39,500 | 55 K to 39.5 K (-28.17 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 63.64 | 6,505 | 413,978 | 54,994 | 61.5 K to 55 K (-10.58 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 62.79 | 6,883 | 432,184 | 61,499 | 68.4 K to 61.5 K (-10.07 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 61.91 | 4,000 | 247,640 | 68,382 | 72.4 K to 68.4 K (-5.53 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 32,882 | 723,404 | 72,382 | 39.5 K to 72.4 K (+83.25 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 2,667 | 34,911 | 3,333 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 19.50 | 13,125 | 255,938 | 16,875 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 46,517 | 1,023,374 | 108,983 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 2,667 | 162,287 | 39,500 | 42.2 K to 39.5 K (-6.32 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 2,667 | 34,911 | 42,167 | 39.5 K to 42.2 K (+6.75 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 13,125 | 798,656 | 39,500 | 52.6 K to 39.5 K (-24.94 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 19.50 | 13,125 | 255,938 | 52,625 | 39.5 K to 52.6 K (+33.23 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 46,517 | 2,830,559 | 39,500 | 86 K to 39.5 K (-54.08 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 46,517 | 1,023,374 | 86,017 | 39.5 K to 86 K (+117.76 %) |
| Mar 15 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 25,000 | 550,000 | 155,500 | |
| Mar 15 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 33.00 | 25,000 | 825,000 | 39,500 | 64.5 K to 39.5 K (-38.76 %) |
| Mar 15 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 25,000 | 550,000 | 64,500 | 39.5 K to 64.5 K (+63.29 %) |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | A | 35.80 | 55,000 | 1,969,000 | 55,000 | |
| Dec 27 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 30,000 | 660,000 | 180,500 | |
| Dec 27 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 33.03 | 30,000 | 990,900 | 39,500 | 69.5 K to 39.5 K (-43.17 %) |
| Dec 27 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 30,000 | 660,000 | 69,500 | 39.5 K to 69.5 K (+75.95 %) |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 20,000 | 440,000 | 210,500 | |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 1,890 | 24,740 | 6,000 | |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 30.04 | 21,890 | 657,576 | 39,500 | 61.4 K to 39.5 K (-35.66 %) |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 20,000 | 440,000 | 61,390 | 41.4 K to 61.4 K (+48.32 %) |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 1,890 | 24,740 | 41,390 | 39.5 K to 41.4 K (+4.78 %) |
| Dec 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 110 | 1,440 | 7,890 | |
| Dec 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 30.00 | 110 | 3,300 | 39,500 | 39.6 K to 39.5 K (-0.28 %) |
| Dec 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 110 | 1,440 | 39,610 | 39.5 K to 39.6 K (+0.28 %) |
| Nov 29 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 2,000 | 26,180 | 8,000 | |
| Nov 29 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 29.31 | 2,000 | 58,620 | 39,500 | 41.5 K to 39.5 K (-4.82 %) |
| Nov 29 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 2,000 | 26,180 | 41,500 | 39.5 K to 41.5 K (+5.06 %) |
| Jan 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | A | 19.50 | 30,000 | 585,000 | 30,000 | |
| Dec 12 2016 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Grant | A | 0.00 | 39,500 | 0 | 39,500 | 0 to 39.5 K |
| Feb 01 2016 | RGNX | REGENXBIO Inc. | Simpson Curran | See Remarks | Option Exercise | A | 13.09 | 10,000 | 130,900 | 10,000 | |
| Sep 17 2015 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP of Technical Op ... | Option Exercise | A | 22.00 | 230,500 | 5,071,000 | 230,500 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 9.01 | 15,074 | 135,817 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 12.38 | 3,139 | 38,861 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 9.78 | 1 | 10 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 10.89 | 35,000 | 381,150 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 8.23 | 108,000 | 888,840 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 0.52 | 110,000 | 57,200 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 4.92 | 73,392 | 361,089 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 10.62 | 50,000 | 531,000 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | D | 12.56 | 9,193 | 115,464 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | U | 14.25 | 18,000 | 256,500 | 0 | 18 K to 0 (-100.00 %) |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | U | 14.25 | 15,882 | 226,319 | 18,000 | 33.9 K to 18 K (-46.87 %) |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | U | 14.25 | 8,334 | 118,760 | 33,882 | 42.2 K to 33.9 K (-19.74 %) |
| Mar 20 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Payment of Exercise | F | 7.89 | 2,109 | 16,640 | 42,216 | 44.3 K to 42.2 K (-4.76 %) |
| Mar 13 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | A | 8.23 | 108,000 | 888,840 | 108,000 | |
| Mar 13 2012 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Payment of Exercise | F | 8.23 | 1,640 | 13,497 | 44,150 | 45.8 K to 44.2 K (-3.58 %) |
| Jun 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 12.56 | 22,904 | 287,674 | 9,193 | |
| Jun 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 27.11 | 22,904 | 620,960 | 45,790 | 68.7 K to 45.8 K (-33.34 %) |
| Jun 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 12.56 | 22,904 | 287,674 | 68,694 | 45.8 K to 68.7 K (+50.02 %) |
| May 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 12.38 | 26,861 | 332,539 | 3,139 | |
| May 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 9.78 | 1,154 | 11,286 | 1 | |
| May 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 28.99 | 28,015 | 812,029 | 45,790 | 73.8 K to 45.8 K (-37.96 %) |
| May 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 9.78 | 1,154 | 11,286 | 73,805 | 72.7 K to 73.8 K (+1.59 %) |
| May 02 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 12.38 | 26,861 | 332,539 | 72,651 | 45.8 K to 72.7 K (+58.66 %) |
| Mar 21 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | A | 27.10 | 60,000 | 1,626,000 | 60,000 | |
| Mar 21 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Grant | A | 0.00 | 24,000 | 0 | 45,790 | 21.8 K to 45.8 K (+110.14 %) |
| Mar 15 2011 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Payment of Exercise | F | 29.03 | 3,491 | 101,344 | 21,790 | 25.3 K to 21.8 K (-13.81 %) |
| Oct 04 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 12.56 | 22,903 | 287,662 | 32,097 | |
| Oct 04 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 29.79 | 22,903 | 682,390 | 25,281 | 48.2 K to 25.3 K (-47.53 %) |
| Oct 04 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 12.56 | 22,903 | 287,662 | 48,184 | 25.3 K to 48.2 K (+90.59 %) |
| Aug 27 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 9.78 | 18,461 | 180,549 | 0 | |
| Aug 27 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 28.00 | 18,461 | 516,908 | 25,281 | 43.7 K to 25.3 K (-42.20 %) |
| Aug 27 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 9.78 | 18,461 | 180,549 | 43,742 | 25.3 K to 43.7 K (+73.02 %) |
| Jun 14 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 9.78 | 18,461 | 180,549 | 19,616 | |
| Jun 14 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 26.07 | 18,461 | 481,204 | 25,281 | 43.7 K to 25.3 K (-42.20 %) |
| Jun 14 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 9.78 | 18,461 | 180,549 | 43,742 | 25.3 K to 43.7 K (+73.02 %) |
| Apr 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 30,000 | 326,700 | 35,000 | |
| Apr 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 32.76 | 30,000 | 982,713 | 25,281 | 55.3 K to 25.3 K (-54.27 %) |
| Apr 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 10.89 | 30,000 | 326,700 | 55,281 | 25.3 K to 55.3 K (+118.67 %) |
| Mar 11 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | A | 32.56 | 50,000 | 1,628,000 | 50,000 | |
| Mar 11 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Payment of Exercise | F | 32.56 | 2,498 | 81,335 | 25,281 | 27.8 K to 25.3 K (-8.99 %) |
| Mar 11 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Grant | A | 0.00 | 16,667 | 0 | 27,779 | 11.1 K to 27.8 K (+149.99 %) |
| Feb 16 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 12.38 | 30,000 | 371,400 | 30,000 | |
| Feb 16 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Sell | S | 29.10 | 30,000 | 873,102 | 11,112 | 41.1 K to 11.1 K (-72.97 %) |
| Feb 16 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Buy | M | 12.38 | 30,000 | 371,400 | 41,112 | 11.1 K to 41.1 K (+269.98 %) |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 4,600 | 50,094 | 65,000 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 4,524 | 49,266 | 69,600 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 4,104 | 44,693 | 74,124 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 3,872 | 42,166 | 78,228 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 3,200 | 34,848 | 82,100 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 2,761 | 30,067 | 85,300 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 2,488 | 27,094 | 88,061 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 1,700 | 18,513 | 90,549 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 1,361 | 14,821 | 92,249 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 1,335 | 14,538 | 93,610 | |
| Jan 12 2010 | HGSI | HUMAN GENOME SCIEN ... | Simpson Curran | Sr. VP, Operations | Option Exercise | M | 10.89 | 1,300 | 14,157 | 94,945 |